Abstract: Alkylation of the 5-{4-[(4-bromophenyl)sulfonyl]phenyl}-4-(3/4-methylphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones 3a,b with various alkylation agents, i.e., ethyl bromide, phenacyl bromide and ethyl chloroacetate, afforded the S-substituted 1,2,4-triazoles 4-6a,b. The structures of these new compounds were elucidated by elemental analysis and IR, UV, 1 H-NMR, 13 C--NMR and MS spectroscopy. The newly synthesized products were tested for their antibacterial effects.
INTRODUCTION
A large number of bioactive molecules contain a functionalized 1,2,4-triazole nucleus. Various compounds containing the 1,2,4-triazole ring are well known as drugs. For example, fluconazole, itraconazole and voriconazole are used as antimicrobial drugs; 1 ribavirin has antiviral action, 2 while vorozole, letrozole and anastrozole are non-steroidal drugs used for the treatment of cancer. 3, 4 In addition, various 1,2,4-triazoles are associated with different biological activities. Among 1,2,4-triazole derivatives, mercapto-and thione-substituted 1,2,4--triazole ring systems have been studied and, to date, a variety of antibacterial, antifungal, [5] [6] [7] antitubercular, 8, 9 anti-inflammatory, analgesic, 10, 11 antitumoral, 12,13 antiviral 14 and anticonvulsant 15 properties have been reported for a large number of these compounds.
Furthermore, diphenyl sulfone derivatives were also found to possess antibacterial activity. 16, 17 The incorporation of these two moieties into a single molecule and alkylation of the -SH group can change the activity of the obtained novel compounds.
Prompted by the observed biological activities of the above-mentioned compounds and in continuation of ongoing research on the synthesis of heterocyclic compounds containing nitrogen and sulfur with expected biological activity, [18] [19] [20] [21] the synthesis and characterization of several S-alkylated 1,2,4-triazoles are described in this report. All the newly synthesized compounds were characterized by IR, UV-Vis, 1 H-and 13 C-NMR spectroscopy. In addition, the structure of compounds 4a,b, 5b and 6b were confirmed by mass spectrometry. These new compounds were investigated for their antimicrobial activity.
EXPERIMENTAL

Materials, methods and instruments
Commercially available chemicals and solvents were used as received from Sigma-Aldrich and Merck. The melting points of the new compounds were determined with a Boetius apparatus and are uncorrected. The IR spectra (in KBr pellets) were recorded on a Vertex 70 Bruker spectrometer and the wave numbers are given in cm -1 . The NMR spectra were registered on a Varian Gemini 300 BB spectrometer working at 300 MHz for a 1 H and 75 MHz for 13 C in DMSO-d 6 or CDCl 3 (10/1, v/v). All chemical shifts are reported in δ (ppm) using TMS as the internal standard. The mass spectrum of compound 4a was acquired with a hybrid quadrupole -time of flight (QqTOF) high resolution mass spectrometer model API QStar Pulsar produced by Applied Biosystems/SCIEX. The instrument was operated in the positive ions mode, using an atmospheric pressure pneumatically-assisted electrospray ionization interface (ESI, AB model Turboionspray). The voltage of the mass spectrometer (MS) source was set at 5000 V. Molecular ions were detected in full scan over an adequate mass range. Stock solutions were prepared at 1 mg/ml in DMSO. The sample solution (2 μg/ml in water/methanol 1/1, v/v) was introduced by direct infusion at a flow rate of 20 μl/min into the MS interface by means of a built-in Harvard syringe pump. The mass spectra of the compounds 4b, 5b and 6b were registered using a Varian 1200 L/MS/MS triple quadrupole mass spectrometer coupled with a high performance liquid chromatograph operating with a Varian ProStar 240 pump and a Varian ProStar 410 automatic injector. An atmospheric pressure chemical ionization interface (APCI) was used in order to obtain the ions. The liquid chromatography was performed on a Hypersil Gold (Thermo) column with a pre-column; the mobile phase was 30 % water and 70 % methanol. The UV-Vis spectra were measurement on a SPECORD 40 Analytik, Jena, in methanolic solution (2.5×10 -5 mol/l). The elemental analyses were performed with ECS 40-10, COSTEH instrument.
General procedure for the preparation of new S-alkylated 1,2,4-triazoles
To a stirred solution of 1,2,4-triazole-3-thione 3a,b (1.0 mmol) and sodium ethoxide (1.0 mmol of sodium dissolved in 10 mL ethanol) was added the alkylation agent (1.0 mmol). The reaction mixture was stirred at room temperature for 12 h, and then poured into ice water. The crude product was filtered off, washed with water and recrystallized from ethanol.
Biological activity
The compounds were tested for their in vitro growth inhibitory activity against the following Gram-negative bacteria: Acinetobacter baumannii (Ab) ATCC 19606; Citrobacter freundii (Cf) ATCC 8090, Escherichia coli (Ec) ATCC 11775 and Pseudomonas aeruginosa (Pa) ATCC 9027, and the following Gram-positive bacteria: Enterococcus faecalis (Ef) ATCC 19433, Staphylococcus aureus (Sa) ATCC 12600, Staphylococcus epidermidis (Se) ATCC 14990 and Bacillus cereus (Bc) ATCC 14579, using the paper disk diffusion method. 22 Suspensions in sterile peptone water from 24 h cultures of micro-organisms were adjusted to 0.5 McFarland. Mueller-Hinton Petri dishes of 90 mm diameter were inoculated using these suspensions. Paper disks (5 mm in diameter) containing 10 μL of the to be tested substance (at a concentration of 2048 μg/mL in DMSO) were placed in a circular pattern in each inoculated plate. The plates were incubated at 37 °C for 18-24 h. The inhibitory activity was measured (in mm) as the diameter of the observed inhibition zones. The tests were repeated to confirm the findings and the average of the readings was taken into consideration. Discs with only DMSO were used as the control and ampicillin (10 µg/50µL) served as the control drug.
RESULTS AND DISCUSSIONS
Chemistry
The key intermediates used in the synthesis of the S-alkylated 1,2,4-triazoles, the 5-{4-[(4-bromophenyl)sulfonyl]phenyl}-4-(3/4-methylphenyl)-2,4-dihydro-3H--1,2,4-triazole-3-thiones 3a and 3b, [23] [24] [25] were prepared starting from 4-[(4-bromophenyl)sulfonyl]benzoic acid hydrazide 1. 26 The reaction of 1 with 3-or 4-methylphenyl isothiocyanates in refluxing ethanol gave the
were synthesized by treating the corresponding thiosemicarbazides 2a,b with 8 % NaOH. 23, 24, 27 In the present study, the reaction of the 1,2,4-triazoles 3a,b with ethyl bromide, phenacyl bromide or ethyl chloroacetate in presence of absolute ethanol gave the new S-alkylated triazoles 4-6a,b.
The synthetic route of the compounds is outlined in Scheme 1. The spectral data of all the newly synthesized compounds are in full agreement with the proposed structures.
Analytical and spectral data of the newly prepared compounds 3-{4-[(4-Bromophenyl)sulfonyl]phenyl}-5-(ethylthio)-4-(3-methylphenyl)-4H--1,2,4-triazole (4a
3-{4-[(4-Bromophenyl)sulfonyl]phenyl}-5-(ethylthio)-4-(4-methylphenyl)-4H--1,2,4-triazole (4b
2-{[5-(4-((4-Bromophenyl)sulfonyl)phenyl)-4-(4-methylphenyl-4H-1,2,4-triazol-3-yl]-thio}-1-phenylethanone (5b
Ethyl 2-{[5-(4-((4-bromophenyl)sulfonyl)phenyl)-4-(3-methylphenyl)-4H-1,2,4--triazol-3yl]thio}acetate (6a
Ethyl 2-{[5-(4-((4-bromophenyl)sulfonyl)phenyl)-4-(4-methylphenyl)-4H-1,2,4--triazol-3yl]thio}acetate (6b)
The infrared absorption spectra of the new S-alkylated 1,2,4-triazoles 4-6a,b confirm the alkylation reaction by the disappearance of the stretching of the NH group, which appeared at ≈ 3400 cm -1 in the spectra of the triazoles 3a,b. 23, 24 In addition, the absence of the absorption band characteristic of the C=S group, which appeared in the spectra of the triazoles 3a,b 23, 24 at ≈ 1240 cm -1 proved that these compounds participated in the alkylation reaction in the thiolic tautomeric form and that substitution occurred at the sulfur atom. 28 The C 3 and C 5 heterocyclic carbons from the new S-alkylated compounds 4-6a,b resonated at 152.99-155.54 ppm and 152.88-153.24 ppm, respectively. The C 3 heterocyclic carbon of these new S-alkylated derivatives is more shielded than the C 3 heterocyclic carbon from 1,2,4-triazole intermediates 3a,b (δ ≈ 169 ppm). 23, 24 These results indicate that the alkylation occurred at the sulfur atom 29 and not at the N 2 nitrogen atom. Data from the literature indicated that if the alkylation had occurred at the N 2 heterocyclic nitrogen, the C 3 heterocyclic carbon would have resonated at 167-173 ppm. 30 
Antimicrobial activity
The potential antibacterial activity of compounds 2-6 towards eight standard strains was investigated. From the data presented in Table I , it may be seen that the thiosemicarbazides 2a and 2b showed the highest inhibition zone diameter against E. coli, P. aeruginosa, S. aureus and S. epidermidis, compared with the other tested compounds. Compounds 2a and 2b showed no inhibitory effects against C. freundii and E. faecalis and they were moderately active against A. baumannii and B. cereus. After cyclization of 2a and 2b forming the 1,2,4-triazoles 3a and 3b, it may be seen how these effects decreased and even completely disappeared in the case of some S-alkylation derivatives. All the tested compounds showed good inhibitory effects against B. cereus. Among the S-alkylated triazoles 4-6, the most active compounds were 6a against B. cereus (15 mm diameter inhibition zone) and 5b against C. freundii (16 mm diameter inhibition zone). This could be explained by electropositive effect of the methyl group attached to the phenyl moiety on the heterocyclic ring, which is overlapped the effect of the C=O group inlaid by the S-alkylation reaction and together favorably influenced the potency of the heterocyclic nuclei.
CONCLUSIONS
This study reports the synthesis of some new S-substituted 1,2,4-triazoles by alkylation, in alkaline media, of 5-{4-[(4-bromophenyl)sulfonyl]phenyl}-4-(3/4--methylphenyl)-2,4-dihydro-3H-1,2,4-triazol-3-thiones 3a,b with various alkylation agents (ethyl bromide, phenacyl bromide and ethyl chloroacetate). The structures of new compounds were determined from spectral data and elemental analyses. The potential antibacterial effects of the synthesized compounds, compared with those of the parent triazoles and ampicillin, were investigated using different standard micro-organisms. The most active compounds were 5b and 6a, which exhibited promising activities against C. freundii and B. cereus. Further investigations are in progress. 
